Material Handling White Papers & Case Studies
-
Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling
7/15/2026
Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.
-
Compaction Simulation For Tablet Technology Transfer And Scale-Up
7/15/2026
Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.
-
Predicting Softgel Stability And Shelf Life Using Accelerated Modeling
7/15/2026
Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.
-
Predicting Drug-Loading Limits In Tablet Formulations
7/15/2026
Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.
-
Modeling Polymer Interactions To Improve Amorphous Solid Dispersion Stability
7/15/2026
Molecular dynamics modeling revealed how hydrogen bonding between PVP and Eudragit drives stable amorphous solid dispersion formation, cutting formulation screening time significantly.
-
Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies
7/15/2026
In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.
-
Spray Dry Biologics For Oral Dosage Forms
5/15/2026
Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.
-
The Importance Of Polymorph Screenings
5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
A Simple And Powerful Solution For Accelerating Dissolution
5/5/2026
Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
Converting From A Spray-Dried Dispersion To A KinetiSol Formulation In <5 Months
2/26/2026
A development team quickly turned a low‑bioavailability, high‑burden formulation into a streamlined, clinically improved version, boosting exposure, simplifying manufacturing, and accelerating progress.